Larsen F S, Ejlersen E, Clemmesen J O, Kirkegaard P, Hansen B A
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark.
Liver Transpl Surg. 1996 Sep;2(5):348-53. doi: 10.1002/lt.500020504.
Under normal conditions cerebral blood flow (CBF) is regulated to secure oxidative brain metabolism, but in patients with fulminant hepatic failure (FHF), insufficient CBF has been suggested to precede cerebral edema and intracranial hypertension. In order to determine if insufficient CBF and hypoxia are present in patients with FHF we increased the mean arterial pressure and measured cerebral metabolism. In six patients with FHF CBF determined by 133Xenon injection technique, transcranial Doppler mean flow velocity in the middle cerebral artery (Vmean) and cerebral metabolism were determined, before and after an increase in mean arterial pressure by norepinephrine infusion. Mean arterial pressure was measured in a radial artery, and blood samples from the radial artery and internal jugular vein allowed calculation of the cerebral arteriovenous oxygen (AVDO2), -glucose (AVDgl), and -lactate (AVDlac) differences. Cerebral metabolic rates (CMRO2,-gl,-lac) were calculated as AVDO2,-gl,-lac times CBF. Mean arterial pressure was raised from 70 (54-105) to 111 (93-128) mm Hg during intravenous infusion of norepinephrine. CBF increased from 34 (12-55) to 47 (27-81) mL . 100g-1. min-1 (p < 0.05) and Vmean from 53 (42-60) to 67 (61-79) cm.s-1 (p < 0.05), whereas CMRO2 (1.4 (0.9-2.4) mL . 100g-1 . min-1), CMRgl (11 (4.8-20) mumol 100g-1 . min-1), and CMRlac (3.2 (0-8.9) mumol . 100g-1 . min-1) remained unchanged. Our finding indicates that cerebral oxidative metabolism is preserved in patients with FHF. Cerebral autoregulation is absent, however, and neuroprotective critical care is suggested to be guided by internal jugular vein oxygen saturation to secure appropriate cerebral oxygenation.
在正常情况下,脑血流量(CBF)会受到调节以确保大脑的氧化代谢,但在暴发性肝衰竭(FHF)患者中,有人提出脑血流量不足先于脑水肿和颅内高压出现。为了确定FHF患者是否存在脑血流量不足和缺氧,我们升高了平均动脉压并测量了脑代谢。对6例FHF患者,在通过去甲肾上腺素输注升高平均动脉压之前和之后,采用133氙注射技术测定脑血流量,测量大脑中动脉的经颅多普勒平均血流速度(Vmean)和脑代谢。在桡动脉测量平均动脉压,并采集桡动脉和颈内静脉的血样以计算脑动静脉氧(AVDO2)、葡萄糖(AVDgl)和乳酸(AVDlac)差值。脑代谢率(CMRO2、CMRgl、CMRl)通过AVDO2、AVDgl、AVDlac乘以CBF来计算。静脉输注去甲肾上腺素期间,平均动脉压从7(54 - 105)mmHg升至111(93 - 128)mmHg。脑血流量从34(12 - 55)增加至47(27 - 81)mL·100g⁻¹·min⁻¹(p < 0.05),Vmean从53(42 - 60)增加至67(61 - 79)cm·s⁻¹(p < 0.05),而CMRO2(1.4(0.9 - 2.4)mL·100g⁻¹·min⁻¹)、CMRgl(11(4.8 - 20)μmol·100g⁻¹·min⁻¹)和CMRl(3.2(0 - 8.9)μmol·100g⁻¹·min⁻¹)保持不变。我们的研究结果表明,FHF患者的脑氧化代谢得以保留。然而,脑自动调节功能缺失,建议通过颈内静脉血氧饱和度来指导神经保护性重症监护,以确保适当的脑氧合。